{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:15:26Z","timestamp":1772892926894,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,8]]},"abstract":"<jats:p>This study goaled to evaluate the ABO\/Rh blood group distribution and its relationship with clinical and biochemical factors in polycystic ovary syndrome (PCOS) patients. ABO\/Rh blood group distribution of the patients and the healthy individuals were compared. In addition, the features of clinical and biochemical factors were compared according to the ABO\/Rh blood groups. Two hundred and sixty-five patients were involved in the study. At the time of diagnosis, hirsutism (86%) and oligomenorrhea (80.9%) were the most prevalent symptoms. There were 166 (62.6%) patients with baseline ultrasonography results consistent with PCOS. In 111 (41.9%) patients, insulin resistance was found. ABO blood group distributions in the patient (42.6% A, 17% B, 9.4% AB, 30.9% O) and control (42% A, 16% B, 8% AB, 34% O) groups were found to be similar (<jats:italic toggle=\"yes\">P<\/jats:italic> = .9). There was no difference between oligomenorrhea, hirsutism, hair loss, acne, obesity, high androgen level, insulin resistance, and ultrasound characteristics according to ABO\/Rh blood groups. In this study, ABO\/Rh blood group distribution in individuals with PCOS was found to be similar to healthy individuals, and it was determined that ABO\/Rh blood group was not a risk factor for PCOS. In addition, no correlation was found between the clinical and biochemical characteristics of the patients at the time of diagnosis and the ABO\/Rh blood group.<\/jats:p>","DOI":"10.1097\/md.0000000000034944","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T14:08:56Z","timestamp":1694182136000},"page":"e34944","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Are ABO\/Rh blood groups A risk factor for polycystic ovary syndrome?"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9953-2231","authenticated-orcid":false,"given":"Ozlem","family":"Dogan","sequence":"first","affiliation":[{"name":"Health Sciences University, Haseki Training and Research Hospital, Department of Endocrinology, Fatih, Istanbul, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls.","volume":"3","author":"Witchel","year":"2019","journal-title":"J Endocr Soc"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1210\/jcem.86.7.7633","article-title":"Characterization of reproductive endocrine disorders in women with epilepsy.","volume":"86","author":"Bilo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS.","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coemr.2020.03.004","article-title":"Polycystic ovary syndrome phenotypes and prevalence: differential impact of diagnostic criteria and clinical versus unselected population.","volume":"12","author":"Mumusoglu","year":"2020","journal-title":"Curr Opin Endocr Metab Res"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/13543784.2020.1781815","article-title":"Current and experimental drug therapy for the treatment of polycystic ovarian syndrome.","volume":"29","author":"Della Corte","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"6629060","DOI":"10.1155\/2021\/6629060","article-title":"Human ABO blood groups and their associations with different diseases.","volume":"2021","author":"Abegaz","year":"2021","journal-title":"Biomed Res Int"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12885-019-5355-4","article-title":"Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review.","volume":"19","author":"Mao","year":"2019","journal-title":"BMC Cancer"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ijc.34533","article-title":"Epidemiological and genetic evidence for the relationship between ABO blood group and human cancer.","volume":"153","author":"Cui","year":"2023","journal-title":"Int J Cancer"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"E109","DOI":"10.1210\/jc.2012-2781","article-title":"Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1.","volume":"98","author":"Weisbrod","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1507\/endocrj.EJ18-0582","article-title":"Investigation of blood groups in benign thyroid diseases in Turkey.","volume":"66","author":"Dagdeviren","year":"2019","journal-title":"Endocr J"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0304-4165(99)00183-X","article-title":"Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer.","volume":"1473","author":"Hakomori","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-1-4615-1267-7_24","article-title":"Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.","volume":"491","author":"Hakomori","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer.","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.fertnstert.2009.07.983","article-title":"Blood group and ovarian hyperstimulation syndrome.","volume":"93","author":"Bellver","year":"2010","journal-title":"Fertil Steril"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13048-022-01075-0","article-title":"Association of ABO blood groups with ovarian reserve: a retrospective cohort study in Chinese Han women younger than 40 years with infertility.","volume":"15","author":"Sun","year":"2022","journal-title":"J Ovarian Res"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12958-020-00685-x","article-title":"Association of ABO blood groups with ovarian reserve, and outcomes after assisted reproductive technology: systematic review and meta-analyses.","volume":"19","author":"Zhao","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.fertnstert.2014.09.008","article-title":"Effect of ABO blood type on ovarian reserve in Chinese women.","volume":"102","author":"Lin","year":"2014","journal-title":"Fertil Steril"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ijc.25339","article-title":"ABO blood group and incidence of epithelial ovarian cancer.","volume":"128","author":"Gates","year":"2011","journal-title":"Int J Cancer"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s10552-012-0059-y","article-title":"ABO blood group and risk of epithelial ovarian cancer within the ovarian cancer association consortium.","volume":"23","author":"Poole","year":"2012","journal-title":"Cancer Causes Control"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.3892\/etm.2015.2416","article-title":"Association of gene polymorphisms in ABO blood group chromosomal regions and menstrual disorders.","volume":"9","author":"Su","year":"2015","journal-title":"Exp Ther Med"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0463.2001.tb00011.x","article-title":"ABH and Lewis histo-blood group antigens in cancer.","volume":"109","author":"Le Pendu","year":"2001","journal-title":"APMIS"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","article-title":"Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity.","volume":"502","author":"Zeng","year":"2020","journal-title":"Clin Chim Acta"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:27:48Z","timestamp":1746325668000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":25,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034944","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]}}}